Leerink Partners Remains Bullish After Opdivo and HCV Help Drive 3Q Beat for Bristol-Myers Squibb (BMY)
Go back to Leerink Partners Remains Bullish After Opdivo and HCV Help Drive 3Q Beat for Bristol-Myers Squibb (BMY)| Bristol-Myers Squibb (NYSE: BMY) | Delayed: 57.94 +0.40 (0.70%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $57.54 | 52 Week High | $77.12 | |||
| Open | $57.44 | 52 Week Low | $49.03 | |||
| Day High | $58.00 | P/E | 37.62 | |||
| Day Low | $57.14 | EPS | $1.54 | |||
| Volume | 7,628,692 | |||||
